Hsa_circ_0000190 Promotes NSCLC Cell Resistance to Cisplatin via the Modulation of the miR-1253/IL-6 Axis
Background. This study explored the mechanistic basis for nonsmall cell lung cancer (NSCLC) cisplatin (DDP) treatment resistance in an effort to define effective approaches to abrogating the emergence of such chemoresistance. Methods. Analyses of NSCLC expression of hsa_circ_0000190, miR-1253, and i...
Saved in:
Main Authors: | Hua He, Tian Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.1155/2024/6647810 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hsa_circ_0003220 Drives Chemoresistance of Human NSCLC Cells by Modulating miR-489-3p/IGF1
by: Shaofeng Xia, et al.
Published: (2023-01-01) -
Hsa_circ_0000479/Hsa-miR-149-5p/RIG-I, IL-6 Axis: A Potential Novel Pathway to Regulate Immune Response against COVID-19
by: Zahra Firoozi, et al.
Published: (2022-01-01) -
circRNA_101277 Influences Cisplatin Resistance of Colorectal Cancer Cells by Modulating the miR-370/IL-6 Axis
by: Qing Lv, et al.
Published: (2022-01-01) -
Hsa_circ_0001304 promotes vascular neointimal hyperplasia accompanied by autophagy activation
by: Shi-Qing Mu, et al.
Published: (2025-01-01) -
Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome
by: Wenhua Tao, et al.
Published: (2016-01-01)